CFTR Delivery to Ciliated Airway Cells by PIV Vectors

通过 PIV 载体将 CFTR 递送至纤毛气道细胞

基本信息

  • 批准号:
    7252023
  • 负责人:
  • 金额:
    $ 34.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-09-06 至 2010-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Cystic fibrosis (CF) lung disease causes dehydration of the surface lining of the respiratory epithelium leading to mucostasis and chronic bacterial infection. The absent gene product in CF is the cystic fibrosis transmembrane conductance regulator (CFTR) protein that regulates fluid homeostatic mechanisms in the airway epithelium. We hypothesize that expression of functional CFTR in the airway epithelium of CF patients will restore CFTR function and thus normal lung function. Gene transfer strategies for CF lung disease have so far failed to show significant CFTR delivery to airway cells in vivo, primarily because the vectors did not efficiently transfer CFTR to the respiratory epithelium after intraluminal delivery. We have found that recombinant parainfluenza viruses (rPIV), infect cultures of human well-differentiated airway cells (HAE) with high efficiency after intraluminal delivery, and that gene transfer is specific to ciliated airway epithelial cells, the cell type requiring correction in CF. The high efficiency of gene transfer by rPIV to ciliated cells, the availability of recombinant versions of PIV and, the capacity to insert large transgenes into the rPIV genome suggests that these viruses may be useful for delivering CFTR to the ciliated airway epithelium of the CF lung. However, currently available PIV vectors are cytotoxic to ciliated cells. Therefore, we propose to generate novel recombinant rPIV-based gene transfer vectors that express human CFTR and test the efficacy and safety of these vectors at correcting the CF phenotype of CF HAE. We will also test the efficency, safety and the influence of the immune system on gene transfer by rPIV-vectors in the nasal epithelium of non-human primates in vivo. The Specific Aims of the proposed study are: 1) Can rPIV-Vectors be Generated for Efficacious and Safe CFTR gene transfer to Ciliated Airway Cells? 2) To Test the Efficacy and Cytotoxicity of rPIV-CFTR vectors on Human Well-Differentiated Airway Epithelial Cells In Vitro; and, 3) To Test the Gene Transfer Efficiency of rPIV-Vectors in the Non-Human Primate Nasal Epithelium In Vivo.
描述(由申请人提供):囊性纤维化(CF)肺部疾病导致呼吸道上皮表面衬里脱水,导致粘液淤滞和慢性细菌感染。在CF中缺失的基因产物是囊性纤维化跨膜传导调节蛋白(CFTR),它调节呼吸道上皮细胞的液体稳态机制。我们假设,在CF患者的呼吸道上皮细胞中表达功能性CFTR将恢复CFTR功能,从而恢复正常的肺功能。到目前为止,治疗慢性肺病的基因转移策略还没有显示出显著的CFTR体内递送到呼吸道细胞,主要是因为载体在腔内递送后没有有效地将CFTR转移到呼吸道上皮细胞。我们发现,重组副流感病毒(RPIV)在腔内输送后高效地感染人高分化的呼吸道细胞(HAE),并且基因转移是针对纤毛呼吸道上皮细胞的,这是CF中需要纠正的细胞类型。RPIV基因转移到纤毛细胞的高效率,重组PIV的可获得性,以及将大量转基因插入rPIV基因组的能力,表明这些病毒可能有助于将CFTR转移到CF肺的纤毛呼吸道上皮。然而,目前可用的PIV载体对纤毛细胞具有细胞毒性。因此,我们建议构建新型的重组rPIV基因转移载体来表达人CFTR,并测试这些载体在纠正CFHAE的CF型方面的有效性和安全性。我们还将在体内测试免疫系统对rPIV载体在非人类灵长类动物鼻黏膜上皮细胞中基因转移的有效性、安全性和影响。本研究的具体目的是:1)能否产生rPIV-Vectors,用于将CFTR基因转移到纤毛细胞?2)检测rPIV-CFTR载体对体外培养的人高分化呼吸道上皮细胞的有效性和细胞毒作用;3)检测rPIV-Vectors在体内非人灵长类鼻黏膜上皮细胞中的基因转移效率。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

RAYMOND J PICKLES其他文献

RAYMOND J PICKLES的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('RAYMOND J PICKLES', 18)}}的其他基金

RSV, Keratins and Distal Airway Infection
RSV、角蛋白和远端气道感染
  • 批准号:
    8969407
  • 财政年份:
    2015
  • 资助金额:
    $ 34.45万
  • 项目类别:
RSV, Keratins and Distal Airway Infection
RSV、角蛋白和远端气道感染
  • 批准号:
    9095203
  • 财政年份:
    2015
  • 资助金额:
    $ 34.45万
  • 项目类别:
Why Are Steroids Ineffective at Suppressing RSV Bronchiolitis
为什么类固醇不能有效抑制 RSV 毛细支气管炎
  • 批准号:
    8429648
  • 财政年份:
    2013
  • 资助金额:
    $ 34.45万
  • 项目类别:
Why Are Steroids Ineffective at Suppressing RSV Bronchiolitis
为什么类固醇不能有效抑制 RSV 毛细支气管炎
  • 批准号:
    8664798
  • 财政年份:
    2013
  • 资助金额:
    $ 34.45万
  • 项目类别:
CFTR Delivery to Ciliated Airway Cells by PIV Vectors
通过 PIV 载体将 CFTR 递送至纤毛气道细胞
  • 批准号:
    7842033
  • 财政年份:
    2009
  • 资助金额:
    $ 34.45万
  • 项目类别:
CFTR Delivery to Ciliated Airway Cells by PIV Vectors
通过 PIV 载体将 CFTR 递送至纤毛气道细胞
  • 批准号:
    7450964
  • 财政年份:
    2005
  • 资助金额:
    $ 34.45万
  • 项目类别:
Viral-Bacterial Interactions in the Airway Epithelium
气道上皮中的病毒-细菌相互作用
  • 批准号:
    7068510
  • 财政年份:
    2005
  • 资助金额:
    $ 34.45万
  • 项目类别:
Viral-Bacterial Interactions in the Airway Epithelium
气道上皮中的病毒-细菌相互作用
  • 批准号:
    6906061
  • 财政年份:
    2005
  • 资助金额:
    $ 34.45万
  • 项目类别:
CFTR Delivery to Ciliated Airway Cells by PIV Vectors
通过 PIV 载体将 CFTR 递送至纤毛气道细胞
  • 批准号:
    6970150
  • 财政年份:
    2005
  • 资助金额:
    $ 34.45万
  • 项目类别:
CFTR Delivery to Ciliated Airway Cells by PIV Vectors
通过 PIV 载体将 CFTR 递送至纤毛气道细胞
  • 批准号:
    7120026
  • 财政年份:
    2005
  • 资助金额:
    $ 34.45万
  • 项目类别:

相似国自然基金

FGF8通过Ras/MEK/ERK信号通路调控apical ES结构影响精子生成的机制研究
  • 批准号:
    81801519
  • 批准年份:
    2018
  • 资助金额:
    21.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Changes in apical cochlear mechanics after cochlear implantation
人工耳蜗植入后耳蜗顶端力学的变化
  • 批准号:
    10730981
  • 财政年份:
    2023
  • 资助金额:
    $ 34.45万
  • 项目类别:
Structural diversity of ceramide moiety responsible for apical membrane function of bladder transitional epithelial cells
负责膀胱移行上皮细胞顶膜功能的神经酰胺部分的结构多样性
  • 批准号:
    23K08792
  • 财政年份:
    2023
  • 资助金额:
    $ 34.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of photodynamic diagnosis for apical periodontitis based on 5-ALA fluorescence live imaging
基于5-ALA荧光实时成像的根尖周炎光动力诊断方法的建立
  • 批准号:
    23K09188
  • 财政年份:
    2023
  • 资助金额:
    $ 34.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Epithelial apical membrane polarization, morphogenesis, and regulation of gene expression
上皮顶膜极化、形态发生和基因表达调控
  • 批准号:
    BB/X000575/1
  • 财政年份:
    2023
  • 资助金额:
    $ 34.45万
  • 项目类别:
    Research Grant
Unveiling Functional Roles of Apical Surface Interactions Between Opposing Cell Layers
揭示相对细胞层之间顶端表面相互作用的功能作用
  • 批准号:
    10629101
  • 财政年份:
    2023
  • 资助金额:
    $ 34.45万
  • 项目类别:
Evaluation of Trigeminal Ganglia Sensory Neuronal Population/s Mediating MIF-Induced Anti-Nociception in a Model of Apical Periodontitis.
根尖周炎模型中三叉神经节感觉神经元群介导 MIF 诱导的抗伤害感受的评估。
  • 批准号:
    10822712
  • 财政年份:
    2023
  • 资助金额:
    $ 34.45万
  • 项目类别:
Cell-type specific assembly of apical extracellular matrices
顶端细胞外基质的细胞类型特异性组装
  • 批准号:
    10749768
  • 财政年份:
    2023
  • 资助金额:
    $ 34.45万
  • 项目类别:
Exploring the role of phosphoinositides in the trafficking of proteins to the apical complex in the malaria parasite Plasmodium falciparum.
探索磷酸肌醇在疟原虫恶性疟原虫顶复合体蛋白质运输中的作用。
  • 批准号:
    495093
  • 财政年份:
    2023
  • 资助金额:
    $ 34.45万
  • 项目类别:
    Operating Grants
Étude du rôle de la phosphatase de phosphoinositides SAC1 dans le trafic de protéines au complexe apical chez le parasite de la malaria Plasmodium falciparum
疟疾疟原虫顶端寄生虫复合物中磷酸肌醇磷酸酶 SAC1 的研究
  • 批准号:
    486094
  • 财政年份:
    2022
  • 资助金额:
    $ 34.45万
  • 项目类别:
    Studentship Programs
Illuminating apical extracellular matrix structure and biogenesis
阐明顶端细胞外基质结构和生物发生
  • 批准号:
    10654029
  • 财政年份:
    2022
  • 资助金额:
    $ 34.45万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了